Emergent BioSolutions (EBS) EBITDA Margin (2011 - 2026)
Emergent BioSolutions (EBS) reported EBITDA Margin of -43.15% for Q2 2026, down 60.96 percentage points from 17.81% a year earlier and down 64.93 percentage points from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) EBITDA Margin (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Emergent BioSolutions' EBITDA Margin came in at 3.69%, down 20.71 percentage points year-over-year; for FY2025, it was 26.37%, up 26.36 percentage points from FY2024.
- EBITDA Margin has a five-year change of -8.69 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at 0.01% in FY2024 (+57.31 pp), -57.30% in FY2023 (-54.92 pp), -2.39% in FY2022 (-28.62 pp) and 26.23% in FY2021 (-8.83 pp).
- The Q2 2026 figure ranks as the lowest quarterly EBITDA Margin since Q2 2024.
- Year over year, EBITDA Margin has now declined in each of the last three quarters, with an average year-over-year change of +18.67 percentage points over the last eight quarters.
- The high point for year-over-year EBITDA Margin in five years was Q3 2024 (a gain of 110.09 percentage points); the low point was Q1 2023 (a drop of 81.18 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 21.78% (Q1 2026), -2.96% (Q4 2025) and 43.23% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,157.21 Bn | 1,125.80 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 624.79 Bn | 543.32 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 511.04 Bn | 484.15 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 365.98 Bn | 320.36 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 296.82 Bn | 260.81 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 260.38 Bn | 234.06 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 234.75 Bn | 190.15 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 193.87 Bn | 168.07 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 171.45 Bn | 118.10 Bn | 10.94 Bn | 39.16% |
| 10 | Emergent BioSolutions | 317.34 Mn | -433.56 Mn | 137.20 Mn | -42.47% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -42.47% |
| Mar 31, 2026 | 22.93% |
| Dec 31, 2025 | -1.21% |
| Sep 30, 2025 | 44.31% |
| Jun 30, 2025 | 19.52% |
| Mar 31, 2025 | 34.92% |
| Dec 31, 2024 | 9.60% |
| Sep 30, 2024 | 28.66% |
| Jun 30, 2024 | -66.75% |
| Mar 31, 2024 | 24.83% |
| Dec 31, 2023 | -3.07% |
| Sep 30, 2023 | -77.04% |
| Jun 30, 2023 | -74.31% |
| Mar 31, 2023 | -68.17% |
| Dec 31, 2022 | -5.63% |
| Sep 30, 2022 | -5.00% |
| Jun 30, 2022 | -12.70% |
| Mar 31, 2022 | 12.73% |
| Dec 31, 2021 | 43.25% |
| Sep 30, 2021 | -3.81% |
API Access
Emergent BioSolutions EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();